Frontlight ResearchEarly access
CompletedNo phase
Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit
Key facts
- Who runs it
- Region Skane
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 473 people enrolled
- Started
- 3 Oct 2023
- Ended
- 1 Mar 2024
- Type of study
- Observational
- Treatments tested
- Norepinephrine
- Record updated
- 12 March 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Administration of norepinephrine in a midline catheter in an intermediary care unit
- In Skåne university hospital
- From 2019 to 2023-03-31
Who cannot take part
- Patients who have actively disabled review of their electronic medical record
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a single-center study retrospectively evaluating a local clinical routine to administer norepinephrine in midline catheters, with regard to complications and patient outcomes
Treatments tested
- Norepinephrine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit - a Retrospective Study of Complications and Patient Outcomes
- Publications
- Record updated
- 12 March 2024